Autopsy report · NCT05499624

POMCO2 Clinical Study MicroTrend System pCO2 Sensor

“Change in focus by the company.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 2 months before it stopped.
• 7 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

ExoStat Medical, Inc.

Sponsor type

Industry

Conditions

Hypoperfusion

Interventions

MicroTrend System

Participants

7

Sites

1

Countries

United States

Trials that died the same way

• A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease
  “Company focus shifted” (82% match in meaning)
• A Pilot Study to Explore the Role of Gut Flora in Myasthenia Gravis
  “Company shifted focus” (81% match in meaning)
• Evaluation of Safety and Efficacy of Dehydrated Human Amnion-Intermediate-Chorion Membrane (dHAICM) Allograft in Treatment of Partial Thickness Thermal Burns
  “Change in company strategy.” (71% match in meaning)
• Prospective Evaluation of Heart Failure Patients With Central Sleep Apnea
  “Change in company priorities” (64% match in meaning)
• A Prospective Study of the NUVANCE Facial Rejuvenation System for Mid-Face, Neck and Jowl Rejuvenation Procedures
  “Change in business priorities.” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.